Latest Attention-deficit hyperactivity disorder management Stories
Adding cognitive behavioral therapy â€“ an approach that teaches skills for handling life challenges and revising negative thought patterns â€“ to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients.
NEW YORK, Aug. 23 /PRNewswire/ -- A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed.
DUBLIN, August 10, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced the divestiture of Daytrana(R) (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc.
A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents.
MONMOUTH JUNCTION, N.J., July 28 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved a first-time generic of Methylphenidate Hydrochloride Oral Solution equivalent to brand name MethylinÂ® Oral Solution marketed by Shionogi Pharmaceuticals, Inc. "Tris pursues selective generic opportunities, especially the difficult to formulate or complex formulations and...
DUBLIN and PHILADELPHIA, July 6 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of DaytranaÂ® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years.
MILLER PLACE, N.Y., June 25 /PRNewswire/ -- The Child and Adult Diagnostic and Treatment Program for ADHD, a division of East End Psychological Services, provides testing and state-of-the-art treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan.
BRENTWOOD, Tenn., June 23 /PRNewswire/ -- Learning Lab, Brentwood will present a free seminar, Does My Child Have ADHD? Diagnosing and What's Next?, on Thursday June 24, 2010 from 7:00-8:00 PM at the Maryland Farms YMCA in Brentwood. The seminar will be presented by Dr.
A new study published online in the Journal of Pediatrics suggests that neither attention deficit hyperactivity disorder (ADHD) nor medications used to treat it have a long-term impact on kids' growth.
- To give a box on the ear to.